precision medicine

In the Lab By Elizabeth Cooney

New findings about little-studied cellular compartments could help make chemo more effective

Health By Elizabeth Cooney

Recapping ASCO 2020, talking cancer therapy combinations, and looking to the future

Biotech By Elizabeth Cooney

Startup Spotlight: Aiming to speed precision cancer therapies to children

First Opinion By Richard Cooper and Nigel Paneth

Precision medicine: course correction urgently needed

First Opinion By Gwen Nichols

Precision medicine has a blind spot: children with cancer

First Opinion By Amy DuRoss

To make advanced therapies, we need to industrialize personalization

In the Lab By Karen Weintraub

Growing tumors in a dish, scientists try to personalize pancreatic cancer treatment

Health Tech By Casey Ross

How an AI expert took on his toughest project ever: writing code to save his son’s life

First Opinion By Edward Abrahams

Personalized treatments may be threatened by drug cost-containment proposals

In the Lab By Sharon Begley

The boy was dying. Zebrafish helped save his life

Health Tech By Casey Ross

What if AI in health care is the next asbestos?

First Opinion By Rahul Desikan

I have ALS. I wish a polygenic analysis had told me it was coming

In the Lab By Sharon Begley

Buffalo gave us spicy wings and the ‘book of life.’ Here’s why that’s undermining personalized medicine

Health By Rebecca Robbins, Adam Feuerstein and Damian Garde

He went hunting for gold-standard research on artificial intelligence in medicine — and didn’t find much

First Opinion By Harris A. Gelbard

Multi-target drugs should be in the pharma pipeline along with precision drugs

Business By Rebecca Robbins

With human drugs, a Silicon Valley startup hopes to deliver precision medicine to dogs

Biotech By Jonathan Saltzman — Boston Globe

For one cancer patient, biotech’s genetic test turns out to be a ‘lifesaver’

Health By Liz Szabo — Kaiser Health News

Pricey precision medicine often financially toxic for cancer patients

First Opinion By Richard G. Hamermesh and Kathy E. Giusti

Precision medicine needs a business mindset in order to flourish

First Opinion By Joel C. White

Administrative delays threaten the promise of the 21st Century Cures Act

First Opinion By Franklin W. Maddux

Kidney disease is a killer. More precise classification can help tame it

First Opinion By Robert W. Dubois

Paying for therapies that cure: innovative solutions needed

First Opinion By Akbar K. Waljee, Sameer D. Saini and Brahmajee K. Nallamothu

Doctors could prescribe drugs more accurately — if they could get the data

First Opinion By Chadi Nabhan

Barriers to genomic testing get in the way of precision medicine

First Opinion By Eric Dishman

I handed over my genetic data to the NIH. Here’s why you should, too